COVID-19: impact of vaccination in myeloma patients.
(2022) Annals of hematology — Vol. 101, n° 7, p. 1607-1608 (2022)
Files
277_2022_Article_4799.pdf
Open Access - Adobe PDF
- 501.06 KB
Details
- Authors
Hoornaert, Ellen 
- Abstract
- (en) DEAR EDITOR, The worldwide COVID-19 pandemic represents an unprecedented crisis that affects the entire medical community and appears to be a devastating infection in patients with hematological disorders, including myeloma (MM). Vaccination is therefore crucial in this population . Seroconversion after COVID-19 has been shown to be lower in MM patients compared to the general population. The same is expected after vaccination, as different studies have already reported a lower antibody response after anti-SARS-CoV-2 vaccination in this group. [...]
- Affiliations
Citations
Hoornaert, E., Dachy, F., Hansenne, A., Bailly, S., van Maanen, A., Gruson, D., & Vekemans, M.-C. (2022). COVID-19: impact of vaccination in myeloma patients. Annals of hematology, 101(7), 1607-1608. https://doi.org/10.1007/s00277-022-04799-7 (Original work published 2022)